找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Bioinformatics and Drug Discovery; Richard S. Larson,Tudor I. Oprea Book 2019Latest edition Springer Science+Business Media, LLC, part of

[复制链接]
楼主: 摩擦
发表于 2025-3-25 05:59:24 | 显示全部楼层
发表于 2025-3-25 08:15:37 | 显示全部楼层
,Theorie der räumlichen Kerbwirkung,. Similar to data set preprocessing in other fields, there is an initial need to complete data quality evaluation; however, with large heterogeneous clinical data sets, it is important to standardize the data in order to facilitate dimensionality reduction. This is particularly important for clinica
发表于 2025-3-25 12:55:41 | 显示全部楼层
https://doi.org/10.1007/978-3-642-53069-2ges in gene expression and signal transduction. L1000 big datasets provide gene expression profiles induced by over 10,000 compounds, shRNAs, and kinase inhibitors using L1000 platform. We developed a systematic compound signature discovery pipeline named csNMF, which covers from raw L1000 data proc
发表于 2025-3-25 17:05:02 | 显示全部楼层
High-Throughput Screening for Drug Combinationsed drugs using a full dose-response matrix scheme using viability as the readout. We provide details of the automation required to run the screen and the informatics required to process data from screening robot and subsequent analysis and visualization of the datasets.
发表于 2025-3-25 20:04:11 | 显示全部楼层
Post-processing of Large Bioactivity Datathe processing of large bioactivity data and methods for handling these issues in a post-processing scenario. Specifically described are observations from a recent effort (Harris, ., 2017) to post-process massive amounts of bioactivity data from the NIH’s PubChem Bioassay repository (Wang et al., Nucleic Acids Res 42:1075–1082, 2014).
发表于 2025-3-26 00:38:19 | 显示全部楼层
Isomeric and Conformational Analysis of Small Drug and Drug-Like Molecules by Ion Mobility-Mass Specs are highlighted and placed in the context of both a separation and characterization perspective. We conclude this chapter with a guided reference protocol for obtaining routine IM-MS spectra on a commercially available uniform-field IM-MS.
发表于 2025-3-26 04:20:26 | 显示全部楼层
发表于 2025-3-26 10:10:40 | 显示全部楼层
Drug Signature Detection Based on L1000 Genomic and Proteomic Big Dataessing to drug screening and mechanism generation. The discovered compound signatures of breast cancer were consistent with the LINCS KINOMEscan data and were clinically relevant. In this way, the potential mechanisms of compounds’ efficacy are elucidated by our computational model.
发表于 2025-3-26 14:18:21 | 显示全部楼层
发表于 2025-3-26 19:20:30 | 显示全部楼层
Die Formzahldiagramme und ihre Handhabung,zed by computationally ranking the closeness between a disease network and a drug’s signaling network. Furthermore, we describe the use of the most perturbed HLA genes to assess the safety risk for immune-mediated adverse reactions such as Stevens-Johnson syndrome/toxic epidermal necrolysis.
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-25 15:15
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表